P3 Health Partners Inc. (PIII) Stock Price & Analysis
P3 Health Partners Inc. (PIII) fell 3.96% to USD 8.98 as of September 8, 2026 at 23:40 UTC, according to Nexqual real-time market data.
PIII last closed at USD 8.98; the session ranged USD 8.9–9.32 on volume of 21,287 shares. Market capitalization is —, with a 52-week range of USD 1.52–16.89 (NCM). Source: Nexqual, September 8, 2026 at 23:40 UTC.
Key Statistics (as of September 8, 2026 at 23:40 UTC)
| Price | USD 8.98 |
|---|---|
| Change | ▼ 3.96% (down) |
| Previous Close | USD 8.98 |
| Open | USD 8.98 |
| Day Range | USD 8.9 – 9.32 |
| 52-Week Range | USD 1.52 – 16.89 |
| Volume | 21,287 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (PIII)
Nexqual's technical model rates PIII "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 23:40 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 40.98 (neutral) |
| vs SMA50 | Below (USD 10.35) |
| MACD | -0.43 (negative) |
From P3 Health Partners Inc.'s Latest SEC 10-K Filing (filed 2026-03-26)
Key Strengths & Strategy (as disclosed to the SEC)
- We have developed proprietary technology and processes that support our operational programs and clinical insights, including our P3 Technology/Health Hub, which is a proprietary system that aids in the aggregation and analysis of third-party data we collect.
- Using our proprietary technology platform for integrated data reporting, physicians can stratify their patient panels based on risk.
- P3 Technology/Health Hub The backbone of our P3 Care Model is our proprietary technology platform—P3 Technology/Health Hub—which enables physicians, care teams, patients and their family members to engage in the care journey.
- We staff dedicated care managers and care navigators to help ensure end-to-end patient care across the full continuum.
Partnerships
- We believe that allowing them to maintain their independence increases their engagement with population health management practices, which is key to transforming the healthcare system. • Limited collaboration between PCPs and payors.
- We are "family" and we take care of each other with the same intensity as we take care of our patients. ◦ Collaboration " We achieve more when we work as one. " ◦ Service: "We serve others with empathy, purpose, and a commitment to excellence." • Passion: Our heart is our patients.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HCWB | HCW Biologics Inc. | USD 2.51 | ▼ 12.54% |
| SNAL | Snail, Inc. | USD 2.61 | ▼ 3.33% |
| ERNA | Ernexa Therapeutics Inc. | USD 4.19 | ▼ 7.51% |
| STLN | Starling Oncology, Inc. | USD 6.32 | ▲ 5.86% |
| AKAN | Akanda Corp. | USD 3.28 | ▼ 10.63% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 23:40 UTC. This page is informational and not investment advice.